Tolerogenic Fibroblasts ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 1 |
13. 多発性硬化症／視神経脊髄炎
臨床試験数 : 3,342 / 薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05080270 (ClinicalTrials.gov) | September 21, 2020 | 5/10/2021 | Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis | Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis | Biological: Tolerogenic Fibroblasts | FibroBiologics | NULL | Completed | 18 Years | 55 Years | All | 5 | Early Phase 1 | Mexico |